Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Limited filed a Form S-8 to register additional Class A common shares for its equity incentive plans. The filing covers 3,393,220 shares authorized for issuance under the Amended and Restated Stock Option Plan and 987,016 shares authorized for issuance under the Restricted Stock Plan.
The registration incorporates by reference Afya’s Annual Report on Form 20-F for the year ended December 31, 2024 and subsequent Exchange Act reports. The shares have a par value of $0.00005 per share. This administrative filing expands the pool of shares available for future grants under the company’s employee equity plans.
Afya Limited filed a Form 6-K reporting an operational update. The company announced a medical seats increase at AFYA Faculdade de Ciências Médicas Bragança, as noted in Exhibit 99.1.
The report was signed by Chief Executive Officer Virgilio Deloy Capobianco Gibbon on November 7, 2025.
Afya Limited filed a Form 6-K as a foreign private issuer for October 2025. The filing highlights an exhibit describing the repurchase of its Series A perpetual convertible preferred shares and the repayment of debentures issued by Afya Participações S.A., signaling adjustments to its capital and financing structure.
Afya Limited, a Brazil-based foreign private issuer, submitted a Form 6-K for August 2025. The filing mainly serves to furnish an exhibit titled "Afya Limited Announces a New Share Repurchase Program," indicating the company has authorized a new program to buy back its own shares. The report is signed on behalf of Afya by its Chief Executive Officer, Virgilio Deloy Capobianco Gibbon.